The FMHR traders weigh in on how to play today's weak manufacturing numbers; Goldman's call on an eight-percent drop in the S&P. Also, China's soft economic data. And Mark Schoenebaum, ISI Group analyst, discusses the merger between Bristol-Myers and Amylin Pharma and whether the pharma sector is on the verge of consolidation.
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.
Monday, 17 Jun 2013 | 8:18 PM ETBeijing is hoping that building more cities will create wealth for its people but as CNBC's Eunice Yoon reports, it's also fueling a debilitating rise in property prices.
Monday, 17 Jun 2013 | 5:00 PM ETFundamentals haven't changed enough to substantiate worries that the Fed would cut back on quantitative easing yet, Josh Brown of Fusion Analytics says.